Ferrari, C.; Santo, G.; Merenda, N.; Branca, A.; Mammucci, P.; Pizzutilo, P.; Gadaleta, C.D.; Rubini, G.
Immune Checkpoint Inhibitors in Advanced NSCLC: [18F]FDG PET/CT as a Troubleshooter in Treatment Response. Diagnostics 2021, 11, 1681.
https://doi.org/10.3390/diagnostics11091681
AMA Style
Ferrari C, Santo G, Merenda N, Branca A, Mammucci P, Pizzutilo P, Gadaleta CD, Rubini G.
Immune Checkpoint Inhibitors in Advanced NSCLC: [18F]FDG PET/CT as a Troubleshooter in Treatment Response. Diagnostics. 2021; 11(9):1681.
https://doi.org/10.3390/diagnostics11091681
Chicago/Turabian Style
Ferrari, Cristina, Giulia Santo, Nunzio Merenda, Alessia Branca, Paolo Mammucci, Pamela Pizzutilo, Cosmo Damiano Gadaleta, and Giuseppe Rubini.
2021. "Immune Checkpoint Inhibitors in Advanced NSCLC: [18F]FDG PET/CT as a Troubleshooter in Treatment Response" Diagnostics 11, no. 9: 1681.
https://doi.org/10.3390/diagnostics11091681
APA Style
Ferrari, C., Santo, G., Merenda, N., Branca, A., Mammucci, P., Pizzutilo, P., Gadaleta, C. D., & Rubini, G.
(2021). Immune Checkpoint Inhibitors in Advanced NSCLC: [18F]FDG PET/CT as a Troubleshooter in Treatment Response. Diagnostics, 11(9), 1681.
https://doi.org/10.3390/diagnostics11091681
